- Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study
-
Suzuki T, Nakamura Y, Kato H
- KMID: 2470598
- Osteoporos Sarcopenia.
- 2019 Dec;5(4):122-127.
- doi: 10.1016/j.afos.2019.11.004
OBJECTIVES: Increasing bone mineral density (BMD) to reduce fracture risk is a primary goal of osteoporosis treatment. This prospective, observational study evaluates the effects of monthly minodronate (MIN; 50 mg)... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly minodronate therapy in postmenopausal women with osteoporosis
-
Okimoto N, Arita S, Akahoshi S, Baba K, Fukuhara S, Ishikura T, Yoshioka T, Fuse Y, Okamoto K, Menuki K, Sakai A
- KMID: 2437848
- Osteoporos Sarcopenia.
- 2018 Jun;4(2):59-66.
- doi: 10.1016/j.afos.2018.05.001
OBJECTIVES: The purpose of this study was to investigate the influences of interruption and reinitiation of monthly minodronate therapy on the bone mineral density (BMD) and bone metabolism markers in... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
-
Tanaka M, Nakamura Y, Itoh S, Kato Y
- KMID: 2377001
- Osteoporos Sarcopenia.
- 2017 Mar;3(1):37-44.
- doi: 10.1016/j.afos.2016.12.002
OBJECTIVES: This is an open labeled and retrospective cohort study which compared the effectiveness and safety of ibandronate (IBN) and minodronate (MIN) combined with eldecalcitol (ELD) in primary osteoporosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
-
Kamimura M, Nakamura Y, Ikegami S, Komatsu M, Uchiyama S, Kato H
- KMID: 2368635
- Osteoporos Sarcopenia.
- 2016 Sep;2(3):170-174.
- doi: 10.1016/j.afos.2016.07.002
As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined treatment with minodronate and vitamin C increases bone mineral density and strength in vitamin C-deficient rats
-
Segawa T, Miyakoshi , Kasukawa Y, Aonuma H, Tsuchie H, Shimada Y
- KMID: 2309513
- Osteoporos Sarcopenia.
- 2016 Mar;2(1):30-37.
OBJECTIVES: Reduced bone quality caused by vitamin C deficiency in older persons may lead to incidental fragility fractures during bisphosphonate treatment, although bisphosphonate increases bone mineral density (BMD). This study... -
- CITED
-
- Close
- SHARE
-
- Close
